Impact of Micropapillary Histologic Subtype in Selecting Limited Resection vs Lobectomy for Lung Adenocarcinoma of 2cm or Smaller-Reference-Cited by-同舟云学术

Impact of Micropapillary Histologic Subtype in Selecting Limited Resection vs Lobectomy for Lung Adenocarcinoma of 2cm or Smaller

Published:2013-08-13 Issue:16 Volume:105 Page:1212-1220
ISSN:1460-2105
Container-title:JNCI: Journal of the National Cancer Institute
language:en
Short-container-title:

Author:

Nitadori Jun-ichi,Bograd Adam J.,Kadota Kyuichi,Sima Camelia S.,Rizk Nabil P.,Morales Eduardo A.,Rusch Valerie W.,Travis William D.,Adusumilli Prasad S.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/105/16/1212/17312487/djt166.pdf

Reference40 articles.

1. Occult metastases in lymph nodes predict survival in resectable non-small-cell lung cancer: report of the ACOSOG Z0040 trial;Rusch;J Clin Oncol,2011

2. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group;Ginsberg;Ann Thorac Surg,1995

3. International lung cancer trends by histologic type: male:female differences diminishing and adenocarcinoma rates rising;Devesa;Int J Cancer,2005

4. Reduced lung-cancer mortality with low-dose computed tomographic screening;Aberle;N Engl J Med,2011

Cited by 250 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of postoperative adjuvant therapy on EGFR-mutated stage IA lung adenocarcinoma with micropapillary pathological subtypes;World Journal of Surgical Oncology;2024-09-05

2. Wedge Resection vs Segmentectomy for Clinical Stage IA Non-small Cell Lung Cancer: Are They Truly Oncologically Equivalent?;The Annals of Thoracic Surgery;2024-09

3. A pro-metastatic tRNA fragment drives aldolase A oligomerization to enhance aerobic glycolysis in lung adenocarcinoma;Cell Reports;2024-08

4. Deep-learning-based 3D super-resolution CT radiomics model: Predict the possibility of the micropapillary/solid component of lung adenocarcinoma;Heliyon;2024-07

5. Novel Insights Into the International Association for the Study of Lung Cancer Grading System for Lung Adenocarcinoma;Modern Pathology;2024-07